Patents by Inventor Changsoo Paul Kang

Changsoo Paul Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering
    Patent number: 8530167
    Abstract: The allelic variants or mutations in three genes: GNPTAB, GNPTG and NAGPA, that correlate with stuttering in humans, as well as the encoded mutated polypeptides and related vectors, host cells, antibodies, antibody-producing cell lines and methods of diagnosing, prognosticating and treating stuttering are provided.
    Type: Grant
    Filed: February 8, 2010
    Date of Patent: September 10, 2013
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Centre of Excellence in Molecular Biology Together With All Allied Components, University of Punjab
    Inventors: Dennis T. Drayna, Changsoo Paul Kang, Sheikh Riazuddin
  • DIAGNOSTIC AND THERAPEUTIC USES OF GNPTAB, GNPTG, AND NAGPA IN STUTTERING
    Publication number: 20110313029
    Abstract: The allelic variants or mutations in three genes: GNPTAB, GNPTG and NAGPA, that correlate with stuttering in humans, as well as the encoded mutated polypeptides and related vectors, host cells, antibodies, antibody-producing cell lines and methods of diagnosing, prognosticating and treating stuttering are provided.
    Type: Application
    Filed: February 8, 2010
    Publication date: December 22, 2011
    Applicants: Centre of Excellence in Molecular Biology Together with all Allied Components, University of Punjab, The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Dennis T. Drayna, Changsoo Paul Kang, Sheikh Riazuddin